triazoles has been researched along with Cerebral Infarction in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, M; Baba, S; Dokiya, F; Douchi, T; Kosha, S; Matsuyama, Y; Ohi, Y; Rai, Y; Sagara, Y; Tamada, S | 1 |
| Fujii, A; Hamano, T; Itoh, H; Kuriyama, M; Matsunaga, A; Naganuma, S; Ueno, A; Yoneda, M | 1 |
| Adams, HP; Apostolova, LG; Johnson, EK | 1 |
| Chaney, SF; Hurst, G; Kane, JM; Kehne, JH; McCloskey, TC; Petty, MA; Senyah, Y; White, HS; Wolf, HH; Zobrist, R | 1 |
| Forlani, A; Lozza, G; Mattavelli, A; Monopoli, A; Ongini, E | 1 |
| Higashi, H; Marwaha, AS; Meno, JR; Winn, HR | 1 |
| Beck, T; Bielenberg, GW; Wagener, G | 1 |
7 other study(ies) available for triazoles and Cerebral Infarction
| Article | Year |
|---|---|
Adverse events and bone health during anastrozole therapy in postmenopausal Japanese breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Arthralgia; Bone Density; Breast Neoplasms; Cerebral Infarction; Female; Follow-Up Studies; Fractures, Bone; Humans; Incidence; Japan; Middle Aged; Nitriles; Postmenopause; Retrospective Studies; Survival Rate; Treatment Outcome; Triazoles | 2010 |
[Effects of voriconazole and vascular lesions in invasion of aspergillosis into the central nerve system].
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Cerebral Infarction; Drug Resistance, Fungal; Fatal Outcome; Female; Humans; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Sphenoid Sinusitis; Triazoles; Voriconazole | 2009 |
Disseminated Pseudallescheria boydii infection successfully treated with voriconazole.
Topics: Antifungal Agents; Cerebral Infarction; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mycetoma; Pseudallescheria; Pyrimidines; Subarachnoid Hemorrhage; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Preclinical characterization of MDL 27,192 as a potential broad spectrum anticonvulsant agent with neuroprotective properties.
Topics: Animals; Anticonvulsants; Cerebral Infarction; Craniocerebral Trauma; Electroshock; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Kindling, Neurologic; Male; Mice; Mice, Inbred DBA; Motor Activity; Neuroprotective Agents; Rats; Rats, Inbred F344; Rats, Inbred SHR; Rats, Sprague-Dawley; Seizures; Triazoles; Valproic Acid | 1997 |
Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats.
Topics: Animals; Cerebral Infarction; Dizocilpine Maleate; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Ischemic Attack, Transient; Male; Neuroprotective Agents; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Triazoles | 1998 |
Hippocampal injury and neurobehavioral deficits following hyperglycemic cerebral ischemia: effect of theophylline and ZM 241385.
Topics: Adenosine; Animals; Blood Glucose; Cell Death; Cerebral Infarction; Escape Reaction; Hippocampus; Injections, Intraperitoneal; Male; Maze Learning; Neurons; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Theophylline; Triazines; Triazoles | 2002 |
Infarct reduction by the platelet activating factor antagonist apafant in rats.
Topics: Animals; Azepines; Cerebral Infarction; Cerebrovascular Circulation; Platelet Activating Factor; Rats; Rats, Inbred F344; Triazoles | 1992 |